Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6

Thromb Haemost. 2000 Aug;84(2):195-203.

Abstract

Intra-arterial desmopressin caused dose and time dependent increases (p <0.001 for all) in forearm blood flow (all doses) and plasma tissue plasminogen activator (t-PA) concentrations (desmopressin > or = 70 ng/min). Although plasma t-PA concentrations rose in both forearms, there was a modest local release of t-PA in the infused forearm (14 ng/100 mL of tissue/min, p <0.05). At desmopressin doses > or = 300 ng/min, plasma von Willebrand factor (vWf) and Factor VIII:C concentrations rose in both forearms (p <0.001) and correlated with the rise in interleukin-6 concentrations (r = 0.92, p <0.001: r = 0.85, p = 0.002 respectively). Neither desmopressin nor substance P caused t-PA, vWf or Factor VIII:C release in the patients, although desmopressin increased plasma interleukin-6 concentrations as in healthy volunteers. We conclude that desmopressin releases t-PA, vWf and Factor VIII:C predominantly via systemic mechanisms, possibly mediated by cytokine release. Patients with type 3 vWD appear to have a generalised failure to release t-PA acutely despite a normal interleukin-6 response to desmopressin infusion.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Deamino Arginine Vasopressin / administration & dosage*
  • Deamino Arginine Vasopressin / pharmacology
  • Dose-Response Relationship, Drug
  • Factor VIII / drug effects
  • Factor VIII / metabolism
  • Forearm
  • Hemodynamics / drug effects
  • Humans
  • Infusions, Intra-Arterial
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / blood
  • Substance P / administration & dosage
  • Substance P / pharmacology
  • Time Factors
  • Tissue Plasminogen Activator / blood
  • Tissue Plasminogen Activator / drug effects
  • von Willebrand Diseases / drug therapy*
  • von Willebrand Diseases / physiopathology
  • von Willebrand Factor / drug effects
  • von Willebrand Factor / metabolism

Substances

  • Interleukin-6
  • Plasminogen Activator Inhibitor 1
  • von Willebrand Factor
  • Substance P
  • Factor VIII
  • Tissue Plasminogen Activator
  • Deamino Arginine Vasopressin